AnticoagEvaluator 17+

Name: AnticoagEvaluator
Rating: 3 (2 reviews)
Author: American College of Cardiology

American College of Cardiology

iPad용으로 디자인됨

- 3.0 • 2개의 평가

- 무료

설명

Make well-informed decisions on antithrombotic therapy for your non-valvular AF patients with the updated AnticoagEvaluator.
Use the app to:
• Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed
• Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention
• Generate individualized risk for antithrombotic therapy options based on individual clinical trials.
• Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics.
This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com

2024년 7월 12일

버전 4.3

This app has been updated in accordance with the 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation to incorporate additional stroke risk models (ATRIA, GARFIELD), a mortality risk model (GARFIELD), and updates to the existing stroke and bleed risk calculations. This update also includes updated therapy guidance and renal-adjusted therapy dosing information.

3.0/5

2개의 평가

Top of the screen

Agree with the first review
Top email and risk summary are hidden behind battery and time

Temporary Workaround

It's become less functional since the IOS 8; you can no longer choose a therapy and see the details of its usefulness or the lack thereof. However, here is temporary workaround until they fix it: after selecting the risk factors for your patient, you click on the email icon and it will give you the relative risk reductions for all of the therapies.
I know it's inelegant but is still functional.
Hopefully, they will fix it soon.